Intercontinental Exchange, Inc.
—- Market cap
- —
- Debt
- +$19.64B
- Cash
- −$837.00M
Complete market value, debt and cash evidence is required for enterprise value.
Compare price, profitability, solvency, and SEC-reported financials side by side—before deciding which assumptions deserve a closer look.
FY 2023 · Mkt capMarket cap $45.45B · View financials
Decision snapshot: ICE stock price vs RVMD: inconclusive — current versus $88.37K implied using P/S multiple.
Quick read
Each company valued on the other's multiple, then compared with the market price.
Implied fair value · at RVMD's multiple
Implied fair value · at ICE's multiple
Needs ICE P/S.
Snapshot Sep 8, 11:07 AM ET
Metric by metric
Where each company leads, and how wide the gap is.
Growth edge
Pricing power
Operating leverage
Lower is better
Not comparable
Lower leverage
Statements
Core statements aligned to each company's latest fiscal year.
SEC periods: ICE FY 2025 (ended Dec 31, 2025) · RVMD FY 2023 (ended Dec 31, 2023). Fiscal years are not aligned.
Trendline
Seven fiscal years of revenue, earnings, and margins before underwriting a re-rating.
Price framework
Market cap plus debt, less cash.
Complete market value, debt and cash evidence is required for enterprise value.
Capital structure 100% equity / 0% debt · EV / Revenue 3781.61x
Price framework
The same filing-backed model used on each company's valuation page, with company-specific inputs and calculated scenarios.
Intercontinental Exchange, Inc. · implied price per share
Bear
$60.32
Base
$77.03
Bull
$98.79
Revolution Medicines, Inc. · implied price per share
Latest annual free cash flow must be positive to qualify the filing-backed baseline.
Balance sheet health
Financial health checks to separate durable balance sheets from potential value traps.
Financial strength on a 0–9 scale.
Bankruptcy-risk signal from balance sheet and earnings power.
Debt / equity
Total debt against shareholders' equity
0.68x
0.11x
Net debt / EBITDA
Leverage against operating earnings
2.84x
3.85x
Cash and equivalents
Liquid reserves on the balance sheet
$837.00M
$1.85B
Total debt
Interest-bearing obligations outstanding
Comparable set
Where the pair sits against the wider comparable set.
Keep comparing
Open adjacent comparisons from the same industry to pressure-test the read across multiple pairs.
CME GROUP INC.
ICE vs CME
Cboe Global Markets, Inc.
ICE vs CBOE
NASDAQ, INC.
ICE vs NDAQ
MARKETAXESS HOLDINGS INC
ICE vs MKTX
Tradeweb Markets Inc.
ICE vs TW
S&P Global Inc.
ICE vs SPGI
AMGEN INC
ICE vs AMGN
BRISTOL MYERS SQUIBB CO
ICE vs BMY
GILEAD SCIENCES, INC.
ICE vs GILD
INCYTE CORP
ICE vs INCY
VERTEX PHARMACEUTICALS INC / MA
ICE vs VRTX
Moderna, Inc.
ICE vs MRNA
$19.64B
$193.93M
LLM-powered synthesis
An on-demand narrative read of the same deterministic data.
The deterministic comparison remains available. Sign in when you want an on-demand narrative synthesis of the same data.